318 related articles for article (PubMed ID: 25898876)
1. Procalcitonin-guided antibiotic therapy duration in critically ill adults.
Walker C
AACN Adv Crit Care; 2015; 26(2):99-106. PubMed ID: 25898876
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
[TBL] [Abstract][Full Text] [Related]
4. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
[TBL] [Abstract][Full Text] [Related]
6. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
[TBL] [Abstract][Full Text] [Related]
7. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation.
Heyland DK; Johnson AP; Reynolds SC; Muscedere J
Crit Care Med; 2011 Jul; 39(7):1792-9. PubMed ID: 21358400
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.
Schuetz P; Chiappa V; Briel M; Greenwald JL
Arch Intern Med; 2011 Aug; 171(15):1322-31. PubMed ID: 21824946
[TBL] [Abstract][Full Text] [Related]
11. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis.
Zhang T; Wang Y; Yang Q; Dong Y
BMC Infect Dis; 2017 Jul; 17(1):514. PubMed ID: 28738787
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
[TBL] [Abstract][Full Text] [Related]
14. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.
Albrich WC; Harbarth S
Intensive Care Med; 2015 Oct; 41(10):1739-51. PubMed ID: 26194026
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting.
Deliberato RO; Marra AR; Sanches PR; Martino MD; Ferreira CE; Pasternak J; Paes AT; Pinto LM; dos Santos OF; Edmond MB
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):266-71. PubMed ID: 23711530
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Procalcitonin Assay on Antibiotic Use in Critically Ill Children.
Ross RK; Keele L; Kubis S; Lautz AJ; Dziorny AC; Denson AR; O'Connor KA; Chilutti MR; Weiss SL; Gerber JS
J Pediatric Infect Dis Soc; 2018 May; 7(2):e43-e46. PubMed ID: 29529219
[TBL] [Abstract][Full Text] [Related]
18. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
Harrison M; Collins CD
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.
Layios N; Lambermont B; Canivet JL; Morimont P; Preiser JC; Garweg C; Ledoux D; Frippiat F; Piret S; Giot JB; Wiesen P; Meuris C; Massion P; Leonard P; Nys M; Lancellotti P; Chapelle JP; Damas P
Crit Care Med; 2012 Aug; 40(8):2304-9. PubMed ID: 22809906
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
